1 3 7
S E P T E M B E R 2 0 1 4 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E
Akorn
Akten
(lidocaine hydrochloride ophthalmic
gel) 3.5%
akorn.com
(800) 932-5676
Pricing:
not disclosed
FYI:
This viscous topical gel delivers extended, localized
ocular anesthesia to any eye procedure. A drop or 2 takes
effect in 20 to 60 seconds and lasts for 5 to 30 minutes, a time-
and expense-saving alternative to off-label intracameral injections of
lidocaine 2% jelly. It also spares patients the discomfort of the block injec-
tions. The water-soluble, preservative-free, room-temperature gel can be easily
reapplied for longer cases. Upon its introduction several years ago, it was sold
in sterile 5 mL vials, but its current, smaller portioning in sterile 1 mL tubes
reflects the safety concerns surrounding single-use pharmaceutical packaging.
OSM
O P H T H A L M O L O G Y
with real-time measurements that verify intraocular lens power and the
accuracy of the implants' placement. Alcon plans to integrate the tech-
nology into its cataract refractive suite, which includes the LenSx fem-
tosecond laser, Centurion phacoemulsification system, LuxOR LX3
microscope and Verion measurement and digital marking system which,
the company notes, the ORA complements.
"The marriage of the ORA System and Alcon's Verion image-guided
system is intended to increase the surgeon's clinical confidence when
using IOLs," says Alcon. "Ultimately, the combined technologies are
designed to improve patient outcomes and enhance the overall post-
surgical patient experience with IOLs."
— David Bernard
